US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intellia Therapeutics

8.31

+0.13001.59%

Post-market: 8.500.1900+2.29%19:47 EDT

Volume:1.95M

Turnover:15.91M

Market Cap:860.23M

PE:-1.58

High:8.33

Open:8.12

Low:7.91

Close:8.18

Loading ...

Overview Company News Filings

Trump's FDA Sends a Bullish Signal to Biotech -- Heard on the Street -- WSJ

Intellia Therapeutics Raised to Outperform From Peer Perform by Wolfe Research

Intellia Therapeutics Shares Rise After Upgrade From Wolfe Research

MT Newswires Live

Intellia Therapeutics upgraded at Wolfe on sentiment, valuation

Wolfe Research Upgrades Intellia Therapeutics to Outperform From Peer Perform, Price Target is $21

MT Newswires Live

Intellia Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research

NTLA Lawsuit Alert! Class Action Lawsuit Against Intellia Therapeutics Inc.

Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics announces first patient dosed in MAGNITUDE-2 trial

BRIEF-Intellia Therapeutics Announces First Patient Dosed In The Magnitude-2 Phase 3 Study Of Nexiguran Ziclumeran (Nex-Z), Treatment For Transthyretin (Attr) Amyloidosis With Polyneuropathy

Intellia Therapeutics Inc: Plans to Submit a Biologics Licensing Application for Attrv-Pn by 2028

THOMSON REUTERS

Intellia Therapeutics Announces First Patient Dosed in the Magnitude-2 Phase 3 Study of Nexiguran Ziclumeran (Nex-Z), a One-Time Gene Editing-Based Treatment for Transthyretin (Attr) Amyloidosis With Polyneuropathy

THOMSON REUTERS

Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy

RBC Cuts Price Target on Intellia Therapeutics to $32 From $37, Keeps Outperform, Speculative Risk

MT Newswires Live

Is Intellia Therapeutics, Inc. (NTLA) the Best Gene-Editing Stock to Buy?

Biotech stocks slide as Marks resignation seen being negative for sector

Intellia Focuses on Pipeline Development Amid Stiff Competition

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Wave Life Sciences (WVE)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NTLA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTLA\",,,,,undefined,":{"symbol":"NTLA","market":"US","secType":"STK","nameCN":"Intellia Therapeutics","latestPrice":8.31,"timestamp":1745611200000,"preClose":8.18,"halted":0,"volume":1946473,"hourTrading":{"tag":"盘后","latestPrice":8.5,"preClose":8.31,"latestTime":"19:47 EDT","volume":44265,"amount":367304.5751,"timestamp":1745624845158},"delay":0,"floatShares":97913076,"shares":103517460,"eps":-5.250644,"marketStatus":"Market Closed","change":0.13,"latestTime":"04-25 16:00:00 EDT","open":8.12,"high":8.33,"low":7.91,"amount":15906896.577572001,"amplitude":0.051345,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.250644,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1462507200000,"exchange":"NASDAQ","adjPreClose":8.18,"preHourTrading":{"tag":"盘前","latestPrice":8.13,"preClose":8.18,"latestTime":"09:29 EDT","volume":1372,"amount":11197.103288,"timestamp":1745587799999},"postHourTrading":{"tag":"盘后","latestPrice":8.5,"preClose":8.31,"latestTime":"19:47 EDT","volume":44265,"amount":367304.5751,"timestamp":1745624845158},"volumeRatio":0.630603323761547,"impliedVol":0.9424,"impliedVolPercentile":0.784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTLA\",,,,,undefined,":{"symbol":"NTLA","floatShares":97913076,"roa":"-26.80%","roe":"-54.00%","lyrEps":-5.250644,"volumeRatio":0.630603323761547,"shares":103517460,"dividePrice":0,"high":8.33,"amplitude":0.051345,"preClose":8.18,"low":7.91,"week52Low":5.9,"pbRate":"0.99","psRate":"14.86","week52High":28.18,"institutionHeld":0,"latestPrice":8.31,"eps":-5.250644,"divideRate":0,"volume":1946473,"delay":0,"ttmEps":-5.250644,"open":8.12,"prevYearClose":11.66,"prevWeekClose":7.23,"prevMonthClose":7.11,"prevQuarterClose":7.11,"fiveDayClose":7.23,"twentyDayClose":8.4,"sixtyDayClose":10.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTLA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529229321","title":"Trump's FDA Sends a Bullish Signal to Biotech -- Heard on the Street -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2529229321","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529229321?lang=en_us&edition=fundamental","pubTime":"2025-04-22 17:30","pubTimestamp":1745314200,"startTime":"0","endTime":"0","summary":"For months, investors have feared that Health and Human Services Secretary Robert F. Kennedy Jr. and his Make America Healthy Again movement would derail biomedical innovation. His ousting of Peter Marks -- a senior official at the Food and Drug Administration and key proponent of faster drug approvals -- sent biotech stocks tumbling last month and stoked concerns that the agency was being politicized and turned against science.A more nuanced narrative is now taking shape.While heightened vaccine scrutiny and sweeping FDA staff cuts remain serious threats, recent signals have been more upbeat. In an interview late last week, newly appointed FDA Commissioner Marty Makary -- a former Johns Hopkins surgeon -- delivered a relatively bullish message for the biotech sector. Speaking with Megyn Kelly, Makary said he would speed up approvals for rare-disease treatments, cut reliance on animal testing by incorporating computational models and shorten the industry's typical 10-year drug- develop","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","BK4505","BK4585","BK4207","MFG","BK4563","BK4588","LU1861558580.USD","LU1861559042.SGD","BK4535","BK4556","NTLA","RGNX","BK4139"],"gpt_icon":0},{"id":"2529336042","title":"Intellia Therapeutics Raised to Outperform From Peer Perform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2529336042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529336042?lang=en_us&edition=fundamental","pubTime":"2025-04-22 02:04","pubTimestamp":1745258640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NTLA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2025 14:04 ET (18:04 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTLA"],"gpt_icon":0},{"id":"2529336043","title":"Intellia Therapeutics Shares Rise After Upgrade From Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2529336043","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529336043?lang=en_us&edition=fundamental","pubTime":"2025-04-22 02:00","pubTimestamp":1745258413,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics  shares were up more than 9% in recent trading Monday after Wolfe Research upgraded the company to outperform from peer perform with a price target of $21.Trading volume stood at over 3.8 million shares against a daily average of about 3.4 million shares.Price: 7.88, Change: +0.65, Percent Change: +9.05","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NTLA"],"gpt_icon":0},{"id":"2529758385","title":"Intellia Therapeutics upgraded at Wolfe on sentiment, valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2529758385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529758385?lang=en_us&edition=fundamental","pubTime":"2025-04-21 22:46","pubTimestamp":1745246766,"startTime":"0","endTime":"0","summary":"As previously reported, Wolfe Research analyst Andy Chen upgraded Intellia Therapeutics (NTLA) to Outperform from Peer Perform with a $21 price tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-upgraded-at-wolfe-on-sentiment-valuation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-upgraded-at-wolfe-on-sentiment-valuation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTLA"],"gpt_icon":0},{"id":"2529877720","title":"Wolfe Research Upgrades Intellia Therapeutics to Outperform From Peer Perform, Price Target is $21","url":"https://stock-news.laohu8.com/highlight/detail?id=2529877720","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529877720?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:39","pubTimestamp":1745235595,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics (NTLA) has an average rating of overweight and mean price target of $40.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NTLA"],"gpt_icon":0},{"id":"2529878946","title":"Intellia Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2529878946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529878946?lang=en_us&edition=fundamental","pubTime":"2025-04-21 17:35","pubTimestamp":1745228126,"startTime":"0","endTime":"0","summary":"Wolfe Research upgraded Intellia Therapeutics (NTLA) to Outperform from Peer Perform with a $21 price target Published first on TheFly – the ultima...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-upgraded-to-outperform-from-peer-perform-at-wolfe-research?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-upgraded-to-outperform-from-peer-perform-at-wolfe-research?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTLA"],"gpt_icon":0},{"id":"2527112168","title":"NTLA Lawsuit Alert! Class Action Lawsuit Against Intellia Therapeutics Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2527112168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527112168?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:31","pubTimestamp":1744633871,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against Intellia Therapeutics Inc. ($NTLA) by Levi & Korsinsky on February 11, 2025. The plaintiffs (sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ntla-lawsuit-alert-class-action-lawsuit-against-intellia-therapeutics-inc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ntla-lawsuit-alert-class-action-lawsuit-against-intellia-therapeutics-inc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","BK4556","LU1861558580.USD","BK4585","NTLA","BK4588","BK4139","BK4535"],"gpt_icon":0},{"id":"2526398492","title":"Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple","url":"https://stock-news.laohu8.com/highlight/detail?id=2526398492","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526398492?lang=en_us&edition=fundamental","pubTime":"2025-04-09 21:42","pubTimestamp":1744206178,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Intellia Therapeutics, Inc.  stands against other stocks under $10 that will triple.As we delve into the discussion on stocks that will triple, we must shed light on the U.S. small-cap stocks, which are struggling amid broader market challenges due to ongoing shifts in tariff policy, affecting investors’ confidence. The Russell index  has fallen over 15% from its peak in November 2024 as of the time of writing this article and is down by nearly 19% on a YTD basis. However, the broader market, mostly consisting of large-cap stocks, has only dropped about 14% on a YTD basis. This gap shows how economic uncertainties and higher interest rates have more impact on smaller companies as they typically carry more debt and feel borrowing costs more acutely.Moreover, industry changes and technological advances offer more opportunities to small-cap companies. While the AI bo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intellia-therapeutics-inc-ntla-among-134258664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","TQQQ","BK4139","BK4588","QLD","NTLA","LU1861558580.USD","QID","LU1861559042.SGD","BK4585","BK4535","SQQQ","USAW.SI","USJW.SI","PSQ","TSYW.SI","BK4556","NQmain",".IXIC","MNQmain"],"gpt_icon":1},{"id":"2524218240","title":"Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524218240","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524218240?lang=en_us&edition=fundamental","pubTime":"2025-04-04 04:01","pubTimestamp":1743710460,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April 03, 2025  -- Intellia Therapeutics, Inc. , a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on April 1, 2025, it awarded an inducement grant tothree new employees under Intellia’s 2024 Inducement Plan as a material inducement to employment.Intellia Therapeutics, Inc.  is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Since its inception, Intellia has focused on leveraging gene editing technology to develop novel, first-in-class medicines that address important unmet medical needs and advance the treatment paradigm for patients. Intellia’s deep scientific, technical and clinical development experience, along with its people, is helping set the standard for a new class of medicine. To harness the full potential of gene editing, Intellia continues to expand the capabilities of its CRISPR-based platform with novel editing","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intellia-therapeutics-reports-inducement-grants-200100469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BKPKM429.USD","LU2095319765.USD","IE00BGHQF748.EUR","NDAQ","BK4556","USJW.SI","QID","USAW.SI","SQQQ","NTLA","LU2210150020.SGD","BK4585","BK4588","CRSP","QLD","BK4139","IE00B64PRP62.GBP","NVIW.SI","BK4535","BK4611","LU1861558580.USD","IE00B3QW5Z07.USD","PSQ","LU1861559042.SGD","LU2210149790.SGD","BK4112","TQQQ","NQmain","TSYW.SI","MNQmain",".IXIC"],"gpt_icon":1},{"id":"2524031253","title":"Intellia Therapeutics announces first patient dosed in MAGNITUDE-2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524031253","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524031253?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:37","pubTimestamp":1743680224,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics (NTLA) announced the first patient has been dosed in MAGNITUDE-2, a global, pivotal Phase 3 trial of nexiguran ziclumeran, ne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-announces-first-patient-dosed-in-magnitude-2-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intellia-therapeutics-announces-first-patient-dosed-in-magnitude-2-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1861558580.USD","BK4535","BK4139","NTLA","LU1861559042.SGD","BK4556","BK4588"],"gpt_icon":0},{"id":"2524253667","title":"BRIEF-Intellia Therapeutics Announces First Patient Dosed In The Magnitude-2 Phase 3 Study Of Nexiguran Ziclumeran (Nex-Z), Treatment For Transthyretin (Attr) Amyloidosis With Polyneuropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2524253667","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524253667?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:35","pubTimestamp":1743680133,"startTime":"0","endTime":"0","summary":"BRIEF-Intellia Therapeutics Announces First Patient Dosed In The Magnitude-2Phase 3 Study Of Nexiguran Ziclumeran (Nex-Z), Treatment For Transthyretin (Attr) Amyloidosis With PolyneuropathyApril 3 (Re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nFWN3QH0DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4139","NTLA","BK4585","BK4535","LU1861559042.SGD","BK4588","BK4556"],"gpt_icon":0},{"id":"2524825363","title":"Intellia Therapeutics Inc:  Plans to Submit a Biologics Licensing Application for Attrv-Pn by 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2524825363","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524825363?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:33","pubTimestamp":1743680020,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nFWN3QH0DE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","LU1861558580.USD","LU1861559042.SGD","BK4556","BK4588","BK4585","BK4139","NTLA"],"gpt_icon":0},{"id":"2524347253","title":"Intellia Therapeutics Announces First Patient Dosed in the Magnitude-2 Phase 3 Study of Nexiguran Ziclumeran (Nex-Z), a One-Time Gene Editing-Based Treatment for Transthyretin (Attr) Amyloidosis With Polyneuropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2524347253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524347253?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:33","pubTimestamp":1743680020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nFWN3QH0DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","LU1861558580.USD","LU1861559042.SGD","BK4535","BK4556","NTLA","BK4139"],"gpt_icon":0},{"id":"2524535762","title":"Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2524535762","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524535762?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:30","pubTimestamp":1743679800,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., April  03, 2025  (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/03/3055020/0/en/Intellia-Therapeutics-Announces-First-Patient-Dosed-in-the-MAGNITUDE-2-Phase-3-Study-of-Nexiguran-Ziclumeran-nex-z-a-One-Time-Gene-Editing-Based-Treatment-for-Transthyretin-ATTR-Am.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","CRSP","BK4556","BK4611","LU1861559042.SGD","LU1861558580.USD","NTLA","BK4535","BK4588","BK4139"],"gpt_icon":0},{"id":"2524923007","title":"RBC Cuts Price Target on Intellia Therapeutics to $32 From $37, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2524923007","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524923007?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:16","pubTimestamp":1743679004,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics (NTLA) has an average rating of overweight and mean price target of $41.78, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NTLA"],"gpt_icon":0},{"id":"2524414258","title":"Is Intellia Therapeutics, Inc. (NTLA) the Best Gene-Editing Stock to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524414258","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524414258?lang=en_us&edition=fundamental","pubTime":"2025-04-02 00:41","pubTimestamp":1743525718,"startTime":"0","endTime":"0","summary":"We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Intellia Therapeutics, Inc.  stands against other best gene-editing stocks to buy.Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases. This approach directly alters genetic material to correct mutations, enhance cellular functions, or eliminate disease-causing genes. Industry experts believe that gene editing has the potential to revolutionize the treatment of genetic disorders, cancers, and various other conditions.The number of patients receiving gene therapies is expected to fluctuate over the next decade. In 2020, 16,244 patients were treated, with this figure projected to rise to 94,696 by 2025 before gradually declining to 65,612 by 2034 as existing patient stocks deplete. Over the next decade, an estimated 1.09 million patients could benefit from gene therapies, wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intellia-therapeutics-inc-ntla-best-164158104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","LU0205194284.USD","BK4139","USAW.SI","QLD","LU0205193047.USD","BK4585","HAE","NVIW.SI","BK4556","SQQQ","BK4588","IE00B64QTZ34.USD","IE00BLDYK493.USD","PSQ","TSYW.SI","NQmain","QID","MNQmain","LU1861558580.USD","BK4535","BK4198","TQQQ","LU1169590202.USD","LU0012050646.USD","LU1861559042.SGD","NTLA",".IXIC","LU0106261612.USD","LU1169589451.USD"],"gpt_icon":1},{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRME","FDMT","BK4551","RCKTW","PCRX","GLPG","LEGN","BK4139","MGX","LU0823416689.USD","LU0058720904.USD","VERV","NGNE","CRSP","RCKT","LU1066053197.SGD","LU2023250504.SGD","REGN","LU2362540622.SGD","LU0417517546.SGD","BK4007","TSHA","SRPT","LU1571399168.USD","LU1430594728.SGD","LU1035775433.USD","IE00BZ9MQY76.HKD","DTIL","VRTX","GILD","RNA","BK4568","MRNA","BK4532","KPTI","LU1066051498.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","RGNX","IE00B3T34201.USD","IE0002141913.USD","PTCT","LU2462157665.USD","IE00BFTCPJ56.SGD","BEAM","IE0009355771.USD","MGTX","LU0320765992.SGD","BK4578","LU1069344957.HKD","DYN","NTLA"],"gpt_icon":1},{"id":"2524238924","title":"Intellia Focuses on Pipeline Development Amid Stiff Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2524238924","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524238924?lang=en_us&edition=fundamental","pubTime":"2025-03-31 22:10","pubTimestamp":1743430200,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics, Inc. NTLA is developing its lead CRISPR-based, in vivo genome-editing candidate, nexiguran ziclumeran  for the treatment of transthyretin  amyloidosis.Intellia has collaborated with Regeneron Pharmaceuticals REGN for the development of nex-z.Nex-z is part of the company’s co-development and co-promotion agreement with Regeneron. While NTLA is the lead party in the deal for nex-z, REGN shares 25% of the development costs and commercial profits.Two separate phase III studies are evaluating nex-z for treating transthyretin  amyloidosis with cardiomyopathy  and hereditary transthyretin  amyloidosis with polyneuropathy .Intellia is developing its wholly owned CRISPR-based pipeline candidate, NTLA-2002, for the treatment of hereditary angioedema .The pivotal phase III HAELO study is actively enrolling patients evaluating NTLA-2002 for treating HAE. Intellia dosed the first patient in the HAELO study in January 2025. Enrollment in the same is likely to be completed in t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intellia-focuses-pipeline-development-amid-141000427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2236285917.USD","LU1815336091.USD","LU1974910355.USD","LU2362541513.USD","VERX","LU0114720955.EUR","IE00B19Z9Z06.USD","LU0061475181.USD","LU1093756168.USD","BK4139","LU0823416689.USD","LU1861558580.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU1861559042.SGD","IE00B19Z3581.USD","BK4533","CRSP","BK4556","IE00B19Z9P08.USD","IE00B2B36J28.USD","LU0256863811.USD","REGN","LU2362540622.SGD","LU1917777945.USD","LU1430594728.SGD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1035775433.USD","IE00BZ9MQY76.HKD","LU0289739699.SGD","VRTX","IE00BJT1NW94.SGD","BK4567","LU0882574055.USD","LU2456880835.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU2237438978.USD","IE0002141913.USD","LU0757428866.USD","LU1559883803.SGD","LU0109394709.USD","LU0889565916.HKD","LU1069344957.HKD","LU2089984988.USD","LU0079474960.USD","NTLA","BK4588"],"gpt_icon":0},{"id":"2522504802","title":"Promising Genomics & Synthetic Biology Stocks to Consider in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522504802","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522504802?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:39","pubTimestamp":1743169140,"startTime":"0","endTime":"0","summary":"Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary focus is on characterizing all the genes of an organism, rather than individual genes.The evolution of genomics in the last couple of decades to decode diseases has ushered in a revolutionary era in genetic medicine. There have been several breakthroughs in this field, attracting the attention of pharma and biotech companies. Of late, genomic information is being used to evaluate individual responses to drugs and facilitate the development of targeted therapies.Interestingly, genomics has paved the way for innovative concepts like synthetic biology, which applies engineering principles to biology. Synthetic biology products serve life sciences researchers across a variety of healthcare applications, including drug discovery, disease detection, enzyme engineering, gene editing and basic ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/promising-genomics-synthetic-biology-stocks-133900631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1674673691.USD","LU0320765646.SGD","BEAM","LU1496350502.SGD","LU0689472784.USD","BK4581","LU1989772840.SGD","LU2756315318.SGD","LU1162221912.USD","LU0820561818.USD","LU1551013425.SGD","HD","IE00BWXC8680.SGD","LU0943347566.SGD","RNA","LU1496350171.SGD","LU1035775433.USD","SG9999001440.SGD","LU1674673428.USD","LU0354030511.USD","LU0823411888.USD","LU0079474960.USD","LU1929549753.HKD","BK4585","LU0820562030.AUD","BK4566","IE00BSNM7G36.USD","LU1914381329.SGD","NGS","NTLA","BK4535","LU0942090050.USD","LU0868494617.USD","BK4533","ILMN","LU0868494708.USD","LU1861558580.USD","CRSP","LU2756315664.SGD","BK4179","LU1861559042.SGD","SCD","WVE","TWST","BK4556","IE00B1XK9C88.USD","LU0234572021.USD","IE00BKVL7J92.USD","BK4504","BK4548"],"gpt_icon":0},{"id":"2522838968","title":"Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Wave Life Sciences (WVE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522838968","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522838968?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:20","pubTimestamp":1743002405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intellia Therapeutics (NTLA – Research Report) and W...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-intellia-therapeutics-ntla-and-wave-life-sciences-wve?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-intellia-therapeutics-ntla-and-wave-life-sciences-wve?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4585","BK4556","HCSG","BK4535","BK4137","BK4007","BK4139","WVE","LU1861559042.SGD","NTLA","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":189,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"NTLA","fiscalQuarterEnding":"2024/12","expectedEps":-1.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.24},{"market":"US","date":"2024-11-07","symbol":"NTLA","fiscalQuarterEnding":"2024/09","expectedEps":-1.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-1.34},{"market":"US","date":"2024-08-08","symbol":"NTLA","fiscalQuarterEnding":"2024/06","expectedEps":-1.21,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2024-05-09","symbol":"NTLA","fiscalQuarterEnding":"2024/03","expectedEps":-1.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2024-02-22","symbol":"NTLA","fiscalQuarterEnding":"2023/12","expectedEps":-1.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1708578000000,"reportTimeType":"pre","actualEps":-1.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4643,"hold":0.2143,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4643,"analysts":28,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTLA","date":"2025-04-25","current":-1.631481,"percent":0.986134,"low":-83.48813,"twenty":-31.204003,"median":-9.167075,"eighty":-4.985239,"high":-1.252531,"avg":-16.634385,"sd":17.018082,"marketCap":846772822},"quantilePoints":[{"date":"2020-05-01","current":-6.511881,"twenty":-32.860972,"median":-14.060765,"eighty":-7.712747,"marketCap":648147084},{"date":"2020-05-08","current":-6.40618,"twenty":-32.845934,"median":-14.039919,"eighty":-7.695897,"marketCap":700829733},{"date":"2020-05-15","current":-8.294219,"twenty":-32.837268,"median":-13.980407,"eighty":-7.668844,"marketCap":907379259},{"date":"2020-05-22","current":-9.858191,"twenty":-32.808746,"median":-13.892831,"eighty":-7.677383,"marketCap":1078476254},{"date":"2020-05-29","current":-8.22377,"twenty":-32.800318,"median":-13.875882,"eighty":-7.684886,"marketCap":899672187},{"date":"2020-06-05","current":-10.729766,"twenty":-32.795186,"median":-13.846348,"eighty":-7.694132,"marketCap":1173825627},{"date":"2020-06-12","current":-10.197232,"twenty":-32.777257,"median":-13.768715,"eighty":-7.702486,"marketCap":1115566959},{"date":"2020-06-19","current":-11.16212,"twenty":-32.737017,"median":-13.699683,"eighty":-7.707828,"marketCap":1221124743},{"date":"2020-06-26","current":-10.814127,"twenty":-32.702154,"median":-13.570879,"eighty":-7.709246,"marketCap":1183054722},{"date":"2020-07-02","current":-11.757925,"twenty":-32.68467,"median":-13.435379,"eighty":-7.710996,"marketCap":1286305232},{"date":"2020-07-10","current":-12.554089,"twenty":-32.670843,"median":-13.34277,"eighty":-7.720027,"marketCap":1373404824},{"date":"2020-07-17","current":-11.388842,"twenty":-32.663965,"median":-13.168164,"eighty":-7.741162,"marketCap":1245927938},{"date":"2020-07-24","current":-10.097052,"twenty":-32.65231,"median":-13.149163,"eighty":-7.760646,"marketCap":1104607408},{"date":"2020-07-31","current":-9.390522,"twenty":-32.632914,"median":-13.078845,"eighty":-7.769143,"marketCap":1027313730},{"date":"2020-08-07","current":-10.03218,"twenty":-32.618081,"median":-12.941295,"eighty":-7.782678,"marketCap":1164826355},{"date":"2020-08-14","current":-10.062534,"twenty":-32.586797,"median":-12.85327,"eighty":-7.794251,"marketCap":1168350792},{"date":"2020-08-21","current":-10.259839,"twenty":-32.541974,"median":-12.820737,"eighty":-7.800866,"marketCap":1191259631},{"date":"2020-08-28","current":-10.796103,"twenty":-32.541974,"median":-12.716185,"eighty":-7.808314,"marketCap":1253524681},{"date":"2020-09-04","current":-9.167075,"twenty":-32.532743,"median":-12.671282,"eighty":-7.823209,"marketCap":1064379907},{"date":"2020-09-11","current":-9.743811,"twenty":-32.49507,"median":-12.588542,"eighty":-7.835976,"marketCap":1131344206},{"date":"2020-09-18","current":-11.893926,"twenty":-32.393136,"median":-12.276991,"eighty":-7.83662,"marketCap":1380991811},{"date":"2020-09-25","current":-10.765748,"twenty":-32.366613,"median":-12.145985,"eighty":-7.840543,"marketCap":1250000244},{"date":"2020-10-02","current":-9.526271,"twenty":-32.361603,"median":-12.03405,"eighty":-7.846211,"marketCap":1106085742},{"date":"2020-10-09","current":-13.310471,"twenty":-32.33698,"median":-12.020986,"eighty":-7.848131,"marketCap":1545465528},{"date":"2020-10-16","current":-13.20929,"twenty":-32.286619,"median":-12.058464,"eighty":-7.851509,"marketCap":1533717405},{"date":"2020-10-23","current":-12.587021,"twenty":-32.142446,"median":-12.114597,"eighty":-7.852999,"marketCap":1461466451},{"date":"2020-10-30","current":-12.111467,"twenty":-32.07036,"median":-12.159065,"eighty":-7.857431,"marketCap":1406250275},{"date":"2020-11-06","current":-13.778887,"twenty":-32.036609,"median":-12.272645,"eighty":-7.858977,"marketCap":1657806770},{"date":"2020-11-13","current":-16.31762,"twenty":-32.026542,"median":-12.318889,"eighty":-7.865576,"marketCap":1963254419},{"date":"2020-11-20","current":-15.880584,"twenty":-31.959002,"median":-12.422601,"eighty":-7.878534,"marketCap":1910672522},{"date":"2020-11-27","current":-19.337582,"twenty":-31.740324,"median":-12.526312,"eighty":-7.878534,"marketCap":2326601234},{"date":"2020-12-04","current":-23.321982,"twenty":-31.740324,"median":-12.565131,"eighty":-7.87874,"marketCap":2805984298},{"date":"2020-12-11","current":-28.594125,"twenty":-31.724101,"median":-12.617195,"eighty":-7.881296,"marketCap":3440302111},{"date":"2020-12-18","current":-29.748412,"twenty":-31.665169,"median":-12.672477,"eighty":-7.883854,"marketCap":3579180247},{"date":"2020-12-24","current":-33.361602,"twenty":-31.794994,"median":-12.716185,"eighty":-7.889258,"marketCap":4013901111},{"date":"2020-12-31","current":-29.206166,"twenty":-31.849663,"median":-12.784326,"eighty":-7.893682,"marketCap":3513939820},{"date":"2021-01-08","current":-42.069764,"twenty":-32.054341,"median":-12.833817,"eighty":-7.89818,"marketCap":5061623609},{"date":"2021-01-15","current":-43.964943,"twenty":-32.351582,"median":-12.861927,"eighty":-7.900785,"marketCap":5289642130},{"date":"2021-01-22","current":-39.922251,"twenty":-32.471244,"median":-12.927782,"eighty":-7.90468,"marketCap":4803245681},{"date":"2021-01-29","current":-33.619303,"twenty":-32.541974,"median":-13.010213,"eighty":-7.912798,"marketCap":4044906462},{"date":"2021-02-05","current":-37.15733,"twenty":-32.65231,"median":-13.142644,"eighty":-7.919038,"marketCap":4470584099},{"date":"2021-02-12","current":-36.658033,"twenty":-32.687277,"median":-13.156842,"eighty":-7.921888,"marketCap":4410511230},{"date":"2021-02-19","current":-38.853864,"twenty":-32.764668,"median":-13.188727,"eighty":-7.925309,"marketCap":4674702662},{"date":"2021-02-26","current":-30.505135,"twenty":-32.797883,"median":-13.272941,"eighty":-7.935242,"marketCap":4094734818},{"date":"2021-03-05","current":-26.140772,"twenty":-32.787412,"median":-13.418778,"eighty":-7.940222,"marketCap":3508901934},{"date":"2021-03-12","current":-33.058162,"twenty":-32.797883,"median":-13.53961,"eighty":-7.945771,"marketCap":4437430124},{"date":"2021-03-19","current":-33.148981,"twenty":-32.841261,"median":-13.665167,"eighty":-7.954441,"marketCap":4449620866},{"date":"2021-03-26","current":-32.659567,"twenty":-32.855962,"median":-13.745553,"eighty":-7.959394,"marketCap":4383926311},{"date":"2021-04-01","current":-40.394329,"twenty":-32.901751,"median":-13.768715,"eighty":-7.96365,"marketCap":5422171180},{"date":"2021-04-09","current":-35.641461,"twenty":-33.042877,"median":-13.810384,"eighty":-7.998848,"marketCap":4784189010},{"date":"2021-04-16","current":-35.545597,"twenty":-33.079567,"median":-13.856574,"eighty":-8.000888,"marketCap":4771321005},{"date":"2021-04-23","current":-39.501274,"twenty":-33.199711,"median":-13.890006,"eighty":-8.001585,"marketCap":5302295550},{"date":"2021-04-30","current":-38.959511,"twenty":-33.279806,"median":-13.963259,"eighty":-8.004494,"marketCap":5229574088},{"date":"2021-05-07","current":-31.061863,"twenty":-33.318572,"median":-14.015815,"eighty":-8.011528,"marketCap":4616724660},{"date":"2021-05-14","current":-30.740881,"twenty":-33.28521,"median":-14.044842,"eighty":-8.025907,"marketCap":4569017142},{"date":"2021-05-21","current":-29.10846,"twenty":-33.279806,"median":-14.07567,"eighty":-8.035266,"marketCap":4326390337},{"date":"2021-05-28","current":-34.363389,"twenty":-33.279806,"median":-14.107891,"eighty":-8.063791,"marketCap":5107430559},{"date":"2021-06-04","current":-33.125317,"twenty":-33.291882,"median":-14.138939,"eighty":-8.064468,"marketCap":4923415847},{"date":"2021-06-11","current":-39.109334,"twenty":-33.360242,"median":-14.265743,"eighty":-8.073914,"marketCap":5812820288},{"date":"2021-06-18","current":-34.812764,"twenty":-33.549046,"median":-14.305265,"eighty":-8.096587,"marketCap":5174221084},{"date":"2021-06-25","current":-40.732584,"twenty":-33.686755,"median":-14.399538,"eighty":-8.101905,"marketCap":6054084021},{"date":"2021-07-02","current":-80.309891,"twenty":-33.79464,"median":-14.435997,"eighty":-8.106062,"marketCap":11936459045},{"date":"2021-07-09","current":-75.055973,"twenty":-33.811125,"median":-14.456843,"eighty":-8.107861,"marketCap":11155569201},{"date":"2021-07-16","current":-66.348499,"twenty":-33.900549,"median":-14.49131,"eighty":-8.120591,"marketCap":9861377349},{"date":"2021-07-23","current":-67.555281,"twenty":-33.986237,"median":-14.524593,"eighty":-8.129642,"marketCap":10040741403},{"date":"2021-07-30","current":-69.586207,"twenty":-34.028642,"median":-14.549022,"eighty":-8.130247,"marketCap":10342597981},{"date":"2021-08-06","current":-66.444652,"twenty":-34.074766,"median":-14.589121,"eighty":-8.139081,"marketCap":12295117666},{"date":"2021-08-13","current":-61.710803,"twenty":-34.124222,"median":-14.62368,"eighty":-8.14497,"marketCap":11419152077},{"date":"2021-08-20","current":-59.300194,"twenty":-34.25582,"median":-14.68094,"eighty":-8.159981,"marketCap":10973085708},{"date":"2021-08-27","current":-63.541595,"twenty":-34.351809,"median":-14.738299,"eighty":-8.17737,"marketCap":11757927360},{"date":"2021-09-03","current":-70.20552,"twenty":-34.403028,"median":-14.842498,"eighty":-8.18357,"marketCap":12991039991},{"date":"2021-09-10","current":-63.807675,"twenty":-34.461866,"median":-14.904143,"eighty":-8.18596,"marketCap":11807163680},{"date":"2021-09-17","current":-62.465359,"twenty":-34.510259,"median":-14.929336,"eighty":-8.191347,"marketCap":11558777465},{"date":"2021-09-24","current":-59.228709,"twenty":-34.581042,"median":-14.998845,"eighty":-8.199381,"marketCap":10959858040},{"date":"2021-10-01","current":-53.239914,"twenty":-34.68805,"median":-15.083583,"eighty":-8.206093,"marketCap":9851673386},{"date":"2021-10-08","current":-47.938162,"twenty":-34.7581,"median":-15.118835,"eighty":-8.214255,"marketCap":8870621322},{"date":"2021-10-15","current":-51.822142,"twenty":-34.897583,"median":-15.209402,"eighty":-8.223257,"marketCap":9589324632},{"date":"2021-10-22","current":-52.235162,"twenty":-35.098842,"median":-15.26573,"eighty":-8.225648,"marketCap":9665751160},{"date":"2021-10-29","current":-52.811008,"twenty":-35.312764,"median":-15.347652,"eighty":-8.229704,"marketCap":9772307377},{"date":"2021-11-05","current":-44.057131,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":10082342208},{"date":"2021-11-12","current":-43.000254,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":9840479113},{"date":"2021-11-19","current":-42.105974,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":9635825724},{"date":"2021-11-26","current":-36.78907,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":8419068305},{"date":"2021-12-03","current":-32.854236,"twenty":-35.411398,"median":-15.384375,"eighty":-8.230323,"marketCap":7518593396},{"date":"2021-12-10","current":-37.07524,"twenty":-35.349639,"median":-15.384375,"eighty":-8.230323,"marketCap":8484557390},{"date":"2021-12-17","current":-41.709238,"twenty":-35.349639,"median":-15.384375,"eighty":-8.230323,"marketCap":9545034039},{"date":"2021-12-23","current":-41.237709,"twenty":-35.349639,"median":-15.384375,"eighty":-8.230323,"marketCap":9437125889},{"date":"2021-12-31","current":-38.450806,"twenty":-35.530149,"median":-15.384375,"eighty":-8.230323,"marketCap":8799351511},{"date":"2022-01-07","current":-34.385895,"twenty":-35.552506,"median":-15.410495,"eighty":-8.230942,"marketCap":7869108836},{"date":"2022-01-14","current":-29.712873,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6799701857},{"date":"2022-01-21","current":-26.509723,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6066670629},{"date":"2022-01-28","current":-27.973091,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6401557992},{"date":"2022-02-04","current":-31.205508,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":7141286967},{"date":"2022-02-11","current":-29.729133,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6803422827},{"date":"2022-02-18","current":-28.135688,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":6438767699},{"date":"2022-02-25","current":-26.859462,"twenty":-35.525,"median":-15.410495,"eighty":-8.230942,"marketCap":7195435065},{"date":"2022-03-04","current":-18.129301,"twenty":-35.348693,"median":-15.410495,"eighty":-8.230942,"marketCap":4856694652},{"date":"2022-03-11","current":-17.084023,"twenty":-35.329926,"median":-15.410495,"eighty":-8.230942,"marketCap":4576673050},{"date":"2022-03-18","current":-20.161321,"twenty":-35.148611,"median":-15.410495,"eighty":-8.230942,"marketCap":5401056644},{"date":"2022-03-25","current":-19.693037,"twenty":-35.106305,"median":-15.410495,"eighty":-8.230942,"marketCap":5275606967},{"date":"2022-04-01","current":-21.220536,"twenty":-35.082959,"median":-15.410495,"eighty":-8.230942,"marketCap":5684811867},{"date":"2022-04-08","current":-17.56067,"twenty":-34.829829,"median":-15.410495,"eighty":-8.230942,"marketCap":4704362901},{"date":"2022-04-14","current":-16.704935,"twenty":-34.77825,"median":-15.410495,"eighty":-8.230942,"marketCap":4475118550},{"date":"2022-04-22","current":-14.121008,"twenty":-34.616593,"median":-15.284412,"eighty":-8.230942,"marketCap":3782905151},{"date":"2022-04-29","current":-13.666661,"twenty":-34.451464,"median":-15.186936,"eighty":-8.230942,"marketCap":3661189095},{"date":"2022-05-06","current":-9.790477,"twenty":-34.412825,"median":-15.083583,"eighty":-8.230942,"marketCap":3608368595},{"date":"2022-05-13","current":-10.002464,"twenty":-34.412825,"median":-14.939618,"eighty":-8.227527,"marketCap":3686498082},{"date":"2022-05-20","current":-9.825466,"twenty":-34.412825,"median":-14.86595,"eighty":-8.227527,"marketCap":3621263753},{"date":"2022-05-27","current":-10.033336,"twenty":-34.412825,"median":-14.69367,"eighty":-8.227527,"marketCap":3697876162},{"date":"2022-06-03","current":-9.325342,"twenty":-34.412825,"median":-14.608524,"eighty":-8.227527,"marketCap":3436938849},{"date":"2022-06-10","current":-8.73672,"twenty":-34.412825,"median":-14.559919,"eighty":-8.227527,"marketCap":3219996781},{"date":"2022-06-17","current":-8.8458,"twenty":-34.412825,"median":-14.496638,"eighty":-8.222358,"marketCap":3260199332},{"date":"2022-06-24","current":-10.99242,"twenty":-34.4198,"median":-14.45216,"eighty":-8.221802,"marketCap":4051355196},{"date":"2022-07-01","current":-11.115907,"twenty":-34.4198,"median":-14.326554,"eighty":-8.221802,"marketCap":4096867518},{"date":"2022-07-08","current":-13.046424,"twenty":-34.4198,"median":-14.24317,"eighty":-8.221802,"marketCap":4808376819},{"date":"2022-07-15","current":-13.023784,"twenty":-34.393877,"median":-14.107891,"eighty":-8.221802,"marketCap":4800032893},{"date":"2022-07-22","current":-13.408653,"twenty":-34.393877,"median":-14.060765,"eighty":-8.221802,"marketCap":4941879630},{"date":"2022-07-29","current":-13.328386,"twenty":-34.372391,"median":-14.034076,"eighty":-8.221802,"marketCap":4912296621},{"date":"2022-08-05","current":-12.019714,"twenty":-34.372391,"median":-13.963259,"eighty":-8.221802,"marketCap":4813066162},{"date":"2022-08-12","current":-12.85874,"twenty":-34.372391,"median":-13.887181,"eighty":-8.221802,"marketCap":5149038248},{"date":"2022-08-19","current":-10.687143,"twenty":-34.372391,"median":-13.778887,"eighty":-8.221802,"marketCap":4279463439},{"date":"2022-08-26","current":-11.152214,"twenty":-34.372391,"median":-13.745553,"eighty":-8.221802,"marketCap":4465692310},{"date":"2022-09-02","current":-10.632094,"twenty":-34.305075,"median":-13.570879,"eighty":-8.221802,"marketCap":4257420021},{"date":"2022-09-09","current":-12.232318,"twenty":-34.132479,"median":-13.449815,"eighty":-8.221802,"marketCap":4898199360},{"date":"2022-09-16","current":-12.473396,"twenty":-34.01144,"median":-13.408653,"eighty":-8.221802,"marketCap":4994734326},{"date":"2022-09-23","current":-10.23536,"twenty":-33.846934,"median":-13.20929,"eighty":-8.221802,"marketCap":4098555393},{"date":"2022-09-30","current":-10.622603,"twenty":-33.642926,"median":-13.153704,"eighty":-8.221802,"marketCap":4253619432},{"date":"2022-10-07","current":-10.633992,"twenty":-33.255867,"median":-13.046424,"eighty":-8.221802,"marketCap":4258180139},{"date":"2022-10-14","current":-9.941131,"twenty":-33.075764,"median":-13.003203,"eighty":-8.221802,"marketCap":3980737128},{"date":"2022-10-21","current":-9.533008,"twenty":-32.898327,"median":-12.927782,"eighty":-8.221802,"marketCap":3817311792},{"date":"2022-10-28","current":-10.256241,"twenty":-32.759532,"median":-12.85327,"eighty":-8.221802,"marketCap":4106916689},{"date":"2022-11-04","current":-9.067918,"twenty":-32.42156,"median":-12.772608,"eighty":-8.221802,"marketCap":4008164946},{"date":"2022-11-11","current":-9.781745,"twenty":-32.343735,"median":-12.63095,"eighty":-8.221802,"marketCap":4323687943},{"date":"2022-11-18","current":-8.683413,"twenty":-32.145354,"median":-12.554089,"eighty":-8.221802,"marketCap":3838207422},{"date":"2022-11-25","current":-8.843623,"twenty":-31.734272,"median":-12.453685,"eighty":-8.221802,"marketCap":3909023057},{"date":"2022-12-02","current":-8.893352,"twenty":-31.200993,"median":-12.394776,"eighty":-8.221802,"marketCap":3931003978},{"date":"2022-12-09","current":-7.315997,"twenty":-31.036834,"median":-12.303712,"eighty":-8.186729,"marketCap":3233787748},{"date":"2022-12-16","current":-7.10774,"twenty":-31.036834,"median":-12.181065,"eighty":-8.139081,"marketCap":3141734749},{"date":"2022-12-23","current":-6.745218,"twenty":-31.036834,"median":-12.096289,"eighty":-8.105037,"marketCap":2981494344},{"date":"2022-12-30","current":-6.727863,"twenty":-30.780806,"median":-12.048188,"eighty":-8.071595,"marketCap":2973823261},{"date":"2023-01-06","current":-7.34685,"twenty":-30.780806,"median":-12.011451,"eighty":-8.022919,"marketCap":3247425229},{"date":"2023-01-13","current":-7.258148,"twenty":-30.780806,"median":-11.883807,"eighty":-8.000072,"marketCap":3208217471},{"date":"2023-01-20","current":-6.527319,"twenty":-30.780806,"median":-11.841279,"eighty":-7.94962,"marketCap":2885179633},{"date":"2023-01-27","current":-8.027542,"twenty":-30.780806,"median":-11.720779,"eighty":-7.92253,"marketCap":3548302160},{"date":"2023-02-03","current":-8.336071,"twenty":-30.780806,"median":-11.615966,"eighty":-7.921459,"marketCap":3684676973},{"date":"2023-02-10","current":-7.707443,"twenty":-30.780806,"median":-11.564134,"eighty":-7.919723,"marketCap":3406813292},{"date":"2023-02-17","current":-7.786504,"twenty":-30.780806,"median":-11.435053,"eighty":-7.900785,"marketCap":3441759338},{"date":"2023-02-24","current":-7.005262,"twenty":-30.780806,"median":-11.383801,"eighty":-7.882831,"marketCap":3321797017},{"date":"2023-03-03","current":-8.054009,"twenty":-30.780806,"median":-11.305972,"eighty":-7.878534,"marketCap":3819098373},{"date":"2023-03-10","current":-6.648873,"twenty":-30.780806,"median":-11.259169,"eighty":-7.855127,"marketCap":3152802574},{"date":"2023-03-17","current":-7.395062,"twenty":-30.780806,"median":-11.131334,"eighty":-7.837907,"marketCap":3506634689},{"date":"2023-03-24","current":-7.109208,"twenty":-30.780806,"median":-10.99242,"eighty":-7.795746,"marketCap":3371087063},{"date":"2023-03-31","current":-6.918021,"twenty":-30.767148,"median":-10.928775,"eighty":-7.754037,"marketCap":3280428586},{"date":"2023-04-06","current":-6.643305,"twenty":-30.767148,"median":-10.824667,"eighty":-7.717935,"marketCap":3150162036},{"date":"2023-04-14","current":-7.25956,"twenty":-30.780806,"median":-10.75563,"eighty":-7.702486,"marketCap":3442381594},{"date":"2023-04-21","current":-6.646815,"twenty":-30.780806,"median":-10.727603,"eighty":-7.666625,"marketCap":3151826537},{"date":"2023-04-28","current":-6.745327,"twenty":-30.780806,"median":-10.687143,"eighty":-7.629754,"marketCap":3198539850},{"date":"2023-05-05","current":-8.937919,"twenty":-30.780806,"median":-10.63589,"eighty":-7.595179,"marketCap":3847237929},{"date":"2023-05-12","current":-9.136815,"twenty":-30.780806,"median":-10.597925,"eighty":-7.595179,"marketCap":3932850438},{"date":"2023-05-18","current":-8.968904,"twenty":-30.780806,"median":-10.545224,"eighty":-7.595179,"marketCap":3860574836},{"date":"2023-05-26","current":-8.031059,"twenty":-30.794465,"median":-10.496518,"eighty":-7.592821,"marketCap":3456889157},{"date":"2023-06-02","current":-7.814004,"twenty":-30.794465,"median":-10.454135,"eighty":-7.592821,"marketCap":3363459720},{"date":"2023-06-09","current":-8.878805,"twenty":-30.808123,"median":-10.376198,"eighty":-7.590463,"marketCap":3821792806},{"date":"2023-06-16","current":-9.331346,"twenty":-30.821781,"median":-10.343314,"eighty":-7.588105,"marketCap":4016584367},{"date":"2023-06-23","current":-8.596223,"twenty":-30.834134,"median":-10.309392,"eighty":-7.587674,"marketCap":3700158256},{"date":"2023-06-30","current":-8.375072,"twenty":-30.846488,"median":-10.25804,"eighty":-7.587242,"marketCap":3604966000},{"date":"2023-07-07","current":-8.010582,"twenty":-30.846488,"median":-10.180474,"eighty":-7.587242,"marketCap":3448075059},{"date":"2023-07-14","current":-9.374347,"twenty":-30.846488,"median":-10.098818,"eighty":-7.587242,"marketCap":4035093972},{"date":"2023-07-21","current":-8.862423,"twenty":-30.846488,"median":-10.038831,"eighty":-7.587242,"marketCap":3814741527},{"date":"2023-07-28","current":-8.389406,"twenty":-30.846488,"median":-10.003118,"eighty":-7.587242,"marketCap":3611135868},{"date":"2023-08-04","current":-7.628547,"twenty":-30.846488,"median":-9.900956,"eighty":-7.587242,"marketCap":3459111235},{"date":"2023-08-11","current":-7.718318,"twenty":-30.846488,"median":-9.836152,"eighty":-7.587242,"marketCap":3499817072},{"date":"2023-08-18","current":-7.265562,"twenty":-30.846488,"median":-9.786111,"eighty":-7.577939,"marketCap":3294518068},{"date":"2023-08-25","current":-7.322156,"twenty":-30.846488,"median":-9.730929,"eighty":-7.556571,"marketCap":3320180444},{"date":"2023-09-01","current":-7.31435,"twenty":-30.846488,"median":-9.689582,"eighty":-7.523892,"marketCap":3316640806},{"date":"2023-09-08","current":-7.355332,"twenty":-30.846488,"median":-9.660875,"eighty":-7.513456,"marketCap":3335223905},{"date":"2023-09-15","current":-7.027474,"twenty":-30.871195,"median":-9.607393,"eighty":-7.488251,"marketCap":3186559109},{"date":"2023-09-22","current":-6.543494,"twenty":-30.871195,"median":-9.547953,"eighty":-7.472854,"marketCap":2967101553},{"date":"2023-09-29","current":-6.198072,"twenty":-30.871195,"median":-9.505752,"eighty":-7.463258,"marketCap":2810472572},{"date":"2023-10-06","current":-5.954131,"twenty":-30.871195,"median":-9.459456,"eighty":-7.449694,"marketCap":2699858884},{"date":"2023-10-13","current":-5.641885,"twenty":-30.871195,"median":-9.427209,"eighty":-7.429474,"marketCap":2558273364},{"date":"2023-10-20","current":-5.288658,"twenty":-30.871195,"median":-9.387069,"eighty":-7.397684,"marketCap":2398104745},{"date":"2023-10-27","current":-4.878835,"twenty":-30.938188,"median":-9.374347,"eighty":-7.39481,"marketCap":2212273750},{"date":"2023-11-03","current":-5.167662,"twenty":-30.965508,"median":-9.372489,"eighty":-7.38194,"marketCap":2343240356},{"date":"2023-11-10","current":-4.776282,"twenty":-30.965508,"median":-9.372489,"eighty":-7.36296,"marketCap":2208734112},{"date":"2023-11-17","current":-5.038985,"twenty":-30.965508,"median":-9.372489,"eighty":-7.346996,"marketCap":2330218263},{"date":"2023-11-24","current":-6.009213,"twenty":-30.965508,"median":-9.372489,"eighty":-7.322236,"marketCap":2778888267},{"date":"2023-12-01","current":-5.738091,"twenty":-30.965508,"median":-9.372489,"eighty":-7.312334,"marketCap":2653511420},{"date":"2023-12-08","current":-5.76714,"twenty":-30.938188,"median":-9.372299,"eighty":-7.282952,"marketCap":2666944653},{"date":"2023-12-15","current":-6.169949,"twenty":-30.938188,"median":-9.372299,"eighty":-7.266206,"marketCap":2853218827},{"date":"2023-12-22","current":-5.848476,"twenty":-30.938188,"median":-9.372299,"eighty":-7.263161,"marketCap":2704557708},{"date":"2023-12-29","current":-6.15252,"twenty":-30.965508,"median":-9.372489,"eighty":-7.265991,"marketCap":2845158887},{"date":"2024-01-05","current":-5.716789,"twenty":-30.992828,"median":-9.372679,"eighty":-7.266955,"marketCap":2643660382},{"date":"2024-01-12","current":-5.451477,"twenty":-30.992828,"median":-9.372679,"eighty":-7.266955,"marketCap":2520970181},{"date":"2024-01-19","current":-4.887932,"twenty":-31.020148,"median":-9.373513,"eighty":-7.266635,"marketCap":2260365448},{"date":"2024-01-26","current":-4.858883,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2246932215},{"date":"2024-02-02","current":-4.891805,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2262156546},{"date":"2024-02-09","current":-5.31979,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2460072855},{"date":"2024-02-16","current":-5.513448,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2549627746},{"date":"2024-02-23","current":-5.058484,"twenty":-30.992828,"median":-9.372679,"eighty":-7.265777,"marketCap":2434101937},{"date":"2024-03-01","current":-6.415189,"twenty":-30.965508,"median":-9.372489,"eighty":-7.25352,"marketCap":3086937728},{"date":"2024-03-08","current":-5.995765,"twenty":-30.965508,"median":-9.372489,"eighty":-7.233277,"marketCap":2885114278},{"date":"2024-03-15","current":-5.496451,"twenty":-30.965508,"median":-9.372489,"eighty":-7.154814,"marketCap":2644848265},{"date":"2024-03-22","current":-5.522415,"twenty":-30.965508,"median":-9.372489,"eighty":-7.127982,"marketCap":2657342098},{"date":"2024-03-28","current":-5.396588,"twenty":-30.965508,"median":-9.372489,"eighty":-7.108327,"marketCap":2596795063},{"date":"2024-04-05","current":-4.987151,"twenty":-30.992828,"median":-9.356614,"eighty":-7.0308,"marketCap":2399776932},{"date":"2024-04-12","current":-4.99514,"twenty":-30.992828,"median":-9.325342,"eighty":-7.015215,"marketCap":2403621189},{"date":"2024-04-19","current":-4.272871,"twenty":-30.992828,"median":-9.325342,"eighty":-6.990839,"marketCap":2056071122},{"date":"2024-04-26","current":-4.01233,"twenty":-30.965508,"median":-9.325057,"eighty":-6.956175,"marketCap":1930700932},{"date":"2024-05-03","current":-4.663682,"twenty":-30.965508,"median":-9.325057,"eighty":-6.925258,"marketCap":2244126408},{"date":"2024-05-10","current":-4.938113,"twenty":-30.965508,"median":-9.325057,"eighty":-6.917084,"marketCap":2397463794},{"date":"2024-05-17","current":-5.200312,"twenty":-30.965508,"median":-9.325057,"eighty":-6.889064,"marketCap":2524761767},{"date":"2024-05-24","current":-4.943972,"twenty":-30.965508,"median":-9.325057,"eighty":-6.805129,"marketCap":2400308474},{"date":"2024-05-31","current":-4.391551,"twenty":-30.965508,"median":-9.325057,"eighty":-6.78218,"marketCap":2132106804},{"date":"2024-06-07","current":-4.560457,"twenty":-30.965508,"median":-9.325057,"eighty":-6.745262,"marketCap":2214110911},{"date":"2024-06-14","current":-5.158582,"twenty":-30.992828,"median":-9.325342,"eighty":-6.729125,"marketCap":2504501929},{"date":"2024-06-21","current":-4.798912,"twenty":-31.020148,"median":-9.328344,"eighty":-6.698295,"marketCap":2329881417},{"date":"2024-06-28","current":-4.608148,"twenty":-31.045177,"median":-9.341584,"eighty":-6.683349,"marketCap":2237265012},{"date":"2024-07-05","current":-4.560457,"twenty":-31.045177,"median":-9.341584,"eighty":-6.647638,"marketCap":2214110911},{"date":"2024-07-12","current":-4.894294,"twenty":-31.045177,"median":-9.341584,"eighty":-6.626613,"marketCap":2376189619},{"date":"2024-07-15","current":-5.124801,"twenty":-31.045177,"median":-9.341584,"eighty":-6.584434,"marketCap":2488101107},{"date":"2024-08-02","current":-4.995638,"twenty":-31.199488,"median":-9.325057,"eighty":-6.542633,"marketCap":2425392083},{"date":"2024-08-09","current":-4.243587,"twenty":-31.199488,"median":-9.281795,"eighty":-6.525219,"marketCap":2159119921},{"date":"2024-08-16","current":-4.565909,"twenty":-31.199488,"median":-9.255,"eighty":-6.473837,"marketCap":2323116029},{"date":"2024-08-23","current":-4.591863,"twenty":-31.199488,"median":-9.23848,"eighty":-6.443558,"marketCap":2336321324},{"date":"2024-08-30","current":-4.591863,"twenty":-31.199488,"median":-9.23848,"eighty":-6.414327,"marketCap":2336321324},{"date":"2024-09-06","current":-4.178595,"twenty":-31.199488,"median":-9.23848,"eighty":-6.392758,"marketCap":2126052404},{"date":"2024-09-13","current":-4.126687,"twenty":-31.199488,"median":-9.23848,"eighty":-6.307749,"marketCap":2099641815},{"date":"2024-09-20","current":-4.577887,"twenty":-31.199488,"median":-9.23848,"eighty":-6.207937,"marketCap":2329210780},{"date":"2024-09-27","current":-4.106722,"twenty":-31.199488,"median":-9.23848,"eighty":-6.197556,"marketCap":2089483897},{"date":"2024-10-04","current":-3.523755,"twenty":-31.199488,"median":-9.23848,"eighty":-6.152215,"marketCap":1792872668},{"date":"2024-10-11","current":-3.551706,"twenty":-31.199488,"median":-9.23848,"eighty":-6.124635,"marketCap":1807093754},{"date":"2024-10-18","current":-4.188577,"twenty":-31.199488,"median":-9.23848,"eighty":-6.084285,"marketCap":2131131364},{"date":"2024-10-25","current":-3.164392,"twenty":-31.199488,"median":-9.23848,"eighty":-6.064937,"marketCap":1610030129},{"date":"2024-10-31","current":-2.86093,"twenty":-31.199488,"median":-9.23848,"eighty":-6.032734,"marketCap":1455629764},{"date":"2024-11-08","current":-3.111845,"twenty":-31.200993,"median":-9.238779,"eighty":-5.984307,"marketCap":1625267008},{"date":"2024-11-15","current":-2.948492,"twenty":-31.200993,"median":-9.238779,"eighty":-5.958474,"marketCap":1539950408},{"date":"2024-11-22","current":-2.691084,"twenty":-31.200993,"median":-9.238779,"eighty":-5.89652,"marketCap":1405510293},{"date":"2024-11-29","current":-3.045995,"twenty":-31.200993,"median":-9.238779,"eighty":-5.877007,"marketCap":1590874694},{"date":"2024-12-06","current":-2.661833,"twenty":-31.200993,"median":-9.167075,"eighty":-5.838406,"marketCap":1390233007},{"date":"2024-12-13","current":-2.644283,"twenty":-31.200993,"median":-9.162415,"eighty":-5.787281,"marketCap":1381066636},{"date":"2024-12-20","current":-2.355674,"twenty":-31.200993,"median":-9.160484,"eighty":-5.738914,"marketCap":1230330749},{"date":"2024-12-27","current":-2.363474,"twenty":-31.200993,"median":-9.160484,"eighty":-5.722397,"marketCap":1234404692},{"date":"2025-01-03","current":-2.382975,"twenty":-31.200993,"median":-9.160484,"eighty":-5.662706,"marketCap":1244589549},{"date":"2025-01-10","current":-2.343973,"twenty":-31.202498,"median":-9.16378,"eighty":-5.639393,"marketCap":1224219835},{"date":"2025-01-17","current":-1.836958,"twenty":-31.202498,"median":-9.16378,"eighty":-5.561793,"marketCap":959413548},{"date":"2025-01-24","current":-2.201619,"twenty":-31.202498,"median":-9.16378,"eighty":-5.523214,"marketCap":1149870377},{"date":"2025-01-31","current":-2.049514,"twenty":-31.202498,"median":-9.16378,"eighty":-5.495253,"marketCap":1070428491},{"date":"2025-02-07","current":-1.975412,"twenty":-31.202498,"median":-9.16378,"eighty":-5.46049,"marketCap":1031726034},{"date":"2025-02-14","current":-1.879859,"twenty":-31.202498,"median":-9.16378,"eighty":-5.439567,"marketCap":981820234},{"date":"2025-02-21","current":-2.388825,"twenty":-31.202498,"median":-9.16378,"eighty":-5.373093,"marketCap":1247645007},{"date":"2025-02-28","current":-2.13108,"twenty":-31.202498,"median":-9.16378,"eighty":-5.270155,"marketCap":1106075491},{"date":"2025-03-07","current":-1.974531,"twenty":-31.204003,"median":-9.167075,"eighty":-5.209126,"marketCap":1024822854},{"date":"2025-03-14","current":-1.838906,"twenty":-31.204003,"median":-9.167075,"eighty":-5.170588,"marketCap":954430981},{"date":"2025-03-21","current":-1.735194,"twenty":-31.204003,"median":-9.167075,"eighty":-5.145884,"marketCap":900601902},{"date":"2025-03-28","current":-1.675359,"twenty":-31.204003,"median":-9.167075,"eighty":-5.122767,"marketCap":869546664},{"date":"2025-04-04","current":-1.374194,"twenty":-31.204003,"median":-9.167075,"eighty":-5.062225,"marketCap":713235299},{"date":"2025-04-11","current":-1.35026,"twenty":-31.202498,"median":-9.16378,"eighty":-5.042858,"marketCap":700813204},{"date":"2025-04-17","current":-1.36821,"twenty":-31.202498,"median":-9.16378,"eighty":-4.996433,"marketCap":710129775},{"date":"2025-04-25","current":-1.631481,"twenty":-31.204003,"median":-9.167075,"eighty":-4.985239,"marketCap":846772822}],"updateTime":1745734054997}}}